SCHEMBL29990946

SCHEMBL29990946

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCCCCCCn3cc(CC(=O)O)cn3)cc21

nearest known ligand 0.54

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 18/20 0.54
▸ CRBN Q96SW2 18/20 0.54
▸ PIK3CA P42336 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ ATR Q13535 1/20 0.32
▸ LPAR1 Q92633 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25123105 1.00 DDB1 (0.54) DDB1CRBNPIK3CAMTORATM
SCHEMBL29990767 0.90 CRBN (0.50) DDB1CRBN
SCHEMBL25123219 0.90 CRBN (0.50) DDB1CRBN
SCHEMBL27166508 0.84 CRBN (0.45) DDB1CRBNLPAR1
SCHEMBL30990754 0.84 CRBN (0.64) DDB1CRBN
SCHEMBL25123826 0.84 CRBN (0.64) DDB1CRBN
SCHEMBL25123832 0.84 CRBN (0.64) DDB1CRBN
SCHEMBL21069854 0.84 CRBN (0.64) DDB1CRBN
SCHEMBL22526737 0.84 CRBN (0.64) DDB1CRBN
SCHEMBL23842393 0.84 CRBN (0.64) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback